Can computation validate the final scientific claim?

No. Spontaneous reports cannot estimate incidence or prove causation. Computation can prioritize and eliminate directions; final validation remains with the appropriate domain methods and accountable specialists.

When should the project stop or reframe?

Stop or reframe when the dataset cannot identify the decision-relevant quantity, the result depends on one preprocessing choice, consent or governance forbids the use, or the next conclusion requires clinical, animal, or wet-lab validation.

Computational Science

Pharmacovigilance Signal Data: Hypothesis Generation, Not Incidence

Published 2026-08-22 · Updated 2026-08-22

Answer in brief

Before funding deeper validation, Pharmacovigilance Signal Data should resolve which safety signal deserves structured follow-up. The minimum credible analysis compares distinct routes using reporting bias, duplicates, exposure denominator, confounding, coding, time, and external evidence and attempts to check consistency across independent data types and disproportionality assumptions. The result should name the leading direction, the counterevidence, and the condition that would stop it.

Evidence status: Decision-method guide; not a completed investigation or final validation.

The decision this guide supports

which safety signal deserves structured follow-up

Why the problem is difficult

The article-specific identification challenge is whether the question “which safety signal deserves structured follow-up” can be resolved using reporting bias, duplicates, exposure denominator, confounding, coding, time, and external evidence, rather than merely restated in new language.

A falsifier-first workflow

Define the decision precisely: which safety signal deserves structured follow-up.
Build a source and data ledger around reporting bias, duplicates, exposure denominator, confounding, coding, time, and external evidence.
Compare the inherited route with a mechanistically distinct alternative and a constraint-based null.
Actively search for the strongest counterevidence relevant to this decision, including boundary cases and prior failures.
Run the lowest-cost discriminating challenge: check consistency across independent data types and disproportionality assumptions.
Record pursue, reframe, or stop, the confidence level, the evidence ceiling, and who owns downstream validation.

Decision criteria

Decision impact: would the result materially change the choice about which safety signal deserves structured follow-up?
Evidence fit: does the available evidence—reporting bias, duplicates, exposure denominator, confounding, coding, time, and external evidence—directly address the decision rather than merely correlate with it?
Discrimination: does the preferred route predict an outcome a credible alternative does not?
Robustness: does the ranking survive the challenge “check consistency across independent data types and disproportionality assumptions”?
Validation boundary: is the conclusion no stronger than the available sources, data and computation?

Supporting evidence

reporting bias, duplicates, exposure denominator, confounding, coding, time, and external evidence

Counterevidence

For this decision, a result from “check consistency across independent data types and disproportionality assumptions” that reverses or flattens the ranking must remain visible even when it is commercially inconvenient.

Computation

Here computation earns its place only if it changes the choice about which safety signal deserves structured follow-up or exposes why the available evidence cannot resolve it.

Fastest falsifier

check consistency across independent data types and disproportionality assumptions

When to stop or reframe

A decision-specific stop trigger is failure of the challenge “check consistency across independent data types and disproportionality assumptions” without an independently supported alternative mechanism.

Evidence ceiling

Spontaneous reports cannot estimate incidence or prove causation.

Sources and starting points

NCBI Gene Expression Omnibus — Public functional-genomics data; study design and batch structure must be inspected before reuse.
GTEx Portal — Reference resource for tissue-specific gene expression and regulation.
RCSB Protein Data Bank — Experimentally determined and computed structural biology records with method metadata.
NCBI Sequence Read Archive — Public sequencing data whose consent, design, and technical quality constrain secondary analysis.
ENCODE Project — Additional authoritative starting point selected for this decision area; applicability must be checked against the precise question.
Human Cell Atlas — Additional authoritative starting point selected for this decision area; applicability must be checked against the precise question.

Continue the decision journey

Explore the full topic hub · Editorial standard · Scientific Oracle consulting

Frequently asked questions

What decision does “Pharmacovigilance Signal Data: Hypothesis Generation, Not Incidence” help make?: It supports a bounded decision about which safety signal deserves structured follow-up. The framework keeps alternatives, evidence, counterevidence, uncertainty, and the fastest falsification test visible.
What is the fastest useful test?: check consistency across independent data types and disproportionality assumptions
Can computation validate the final scientific claim?: No. Spontaneous reports cannot estimate incidence or prove causation. Computation can prioritize and eliminate directions; final validation remains with the appropriate domain methods and accountable specialists.
When should the project stop or reframe?: Stop or reframe when the dataset cannot identify the decision-relevant quantity, the result depends on one preprocessing choice, consent or governance forbids the use, or the next conclusion requires clinical, animal, or wet-lab validation.